However, when controlling for HER2/neu status, age, tumor size, nuclear grade, and nodal status, Kothari, et al. reported that individual non-MPD case-controls experienced almost identical overall survival rates as patients with MPD, although the length of follow-up was not specified [10]. Here, ERBB2 is linked to neoplasm.